Alivus Life Sciences Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is -7.07% vs 2.41% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -1.59% vs 8.25% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -1.31% vs -7.24% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -12.08% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Alivus Life With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

640.41

325.89

314.52

96.51%

Other Operating Income

0.00

Total Operating income

640.41

325.89

314.52

96.51%

Raw Material Cost

253.15

70.54

182.61

258.87%

Purchase of Finished goods

0.00

15.67

-15.67

-100.00%

(Increase) / Decrease In Stocks

1.90

-0.54

2.44

451.85%

Employee Cost

68.25

45.02

23.23

51.60%

Power Cost

0.00

29.76

-29.76

-100.00%

Manufacturing Expenses

-0.01

0.01

-0.02

-200.00%

Selling and Distribution Expenses

0.00

Other Expenses

105.41

43.05

62.36

144.85%

Total Expenditure (Excl Depreciation)

428.70

203.51

225.19

110.65%

Operating Profit (PBDIT) excl Other Income

211.71

122.38

89.33

72.99%

Other Income

22.40

15.54

6.86

44.14%

Operating Profit (PBDIT)

234.11

137.92

96.19

69.74%

Interest

1.31

0.06

1.25

2,083.33%

Exceptional Items

0.00

Gross Profit (PBDT)

232.80

137.86

94.94

68.87%

Depreciation

20.59

19.49

1.10

5.64%

Profit Before Tax

212.22

118.38

93.84

79.27%

Tax

52.15

28.36

23.79

83.89%

Provisions and contingencies

0.00

Profit After Tax

160.08

90.02

70.06

77.83%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

160.08

90.02

70.06

77.83%

Equity Capital

24.55

10.46

14.09

134.70%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

13.04

8.61

4.43

51.45%

Diluted Earnings per share

13.01

8.60

4.41

51.28%

Operating Profit Margin (Excl OI)

33.06%

37.55%

0.00

-4.49%

Gross Profit Margin

36.35%

42.30%

0.00

-5.95%

PAT Margin

25.00%

27.62%

0.00

-2.62%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 640.41 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -7.07% vs 2.41% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 6.41% vs 2.25% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 160.08 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -1.59% vs 8.25% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 31.71% vs 9.02% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 211.71 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -1.31% vs -7.24% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 22.87% vs 8.04% in Jun 2025

Quarterly - Interest

Interest 1.31 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -12.08% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 4.80% vs 257.14% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 33.06%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025